These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12785287)

  • 1. Dopaminergic mouse mutants: investigating the roles of the different dopamine receptor subtypes and the dopamine transporter.
    Tan S; Hermann B; Borrelli E
    Int Rev Neurobiol; 2003; 54():145-97. PubMed ID: 12785287
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine receptors and dopamine transporter in brain function and addictive behaviors: insights from targeted mouse mutants.
    Drago J; Padungchaichot P; Accili D; Fuchs S
    Dev Neurosci; 1998; 20(2-3):188-203. PubMed ID: 9691193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geometry and kinetics of dopaminergic transmission in the rat striatum and in mice lacking the dopamine transporter.
    Gonon F; Burie JB; Jaber M; Benoit-Marand M; Dumartin B; Bloch B
    Prog Brain Res; 2000; 125():291-302. PubMed ID: 11098665
    [No Abstract]   [Full Text] [Related]  

  • 4. Cocaine self-administration in dopamine-transporter knockout mice.
    Rocha BA; Fumagalli F; Gainetdinov RR; Jones SR; Ator R; Giros B; Miller GW; Caron MG
    Nat Neurosci; 1998 Jun; 1(2):132-7. PubMed ID: 10195128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic genes and substance abuse.
    Uhl GR; Vandenbergh DJ; Rodriguez LA; Miner L; Takahashi N
    Adv Pharmacol; 1998; 42():1024-32. PubMed ID: 9328073
    [No Abstract]   [Full Text] [Related]  

  • 6. Images in neuroscience. A mouse knockout.
    Caron MG
    Am J Psychiatry; 1996 Nov; 153(11):1387. PubMed ID: 8890669
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperdopaminergic mutant mice have higher "wanting" but not "liking" for sweet rewards.
    Peciña S; Cagniard B; Berridge KC; Aldridge JW; Zhuang X
    J Neurosci; 2003 Oct; 23(28):9395-402. PubMed ID: 14561867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of dopamine receptors and transporter in neuroendocrine gastrointestinal tumor cells.
    Lemmer K; Ahnert-Hilger G; Höpfner M; Hoegerle S; Faiss S; Grabowski P; Jockers-Scherübl M; Riecken EO; Zeitz M; Scherübl H
    Life Sci; 2002 Jun; 71(6):667-78. PubMed ID: 12072155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic mice in drug dependence research.
    Pich EM; Epping-Jordan MP
    Ann Med; 1998 Aug; 30(4):390-6. PubMed ID: 9783838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptor and transporter levels are altered in the brain of Purkinje Cell Degeneration mutant mice.
    Delis F; Mitsacos A; Giompres P
    Neuroscience; 2004; 125(1):255-68. PubMed ID: 15051164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dopaminergic system in attention deficit/hyperactivity disorder.
    Ohno M
    Congenit Anom (Kyoto); 2003 Jun; 43(2):114-22. PubMed ID: 12893970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter.
    Gainetdinov RR; Mohn AR; Bohn LM; Caron MG
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11047-54. PubMed ID: 11572967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential alterations in the mesolimbic dopamine pathway of heterozygous reeler mice: an emerging animal-based model of schizophrenia.
    Ballmaier M; Zoli M; Leo G; Agnati LF; Spano P
    Eur J Neurosci; 2002 Apr; 15(7):1197-205. PubMed ID: 11982630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New clues to brain dopamine control, cocaine addiction.
    Balter M
    Science; 1996 Feb; 271(5251):909. PubMed ID: 8584927
    [No Abstract]   [Full Text] [Related]  

  • 15. Opioid receptor gene expression in dopamine transporter knock-out mice in adult and during development.
    Le Moine C; Fauchey V; Jaber M
    Neuroscience; 2002; 112(1):131-9. PubMed ID: 12044478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical individuality: genetic diversity among human dopamine and serotonin receptors and transporters.
    Cravchik A; Goldman D
    Arch Gen Psychiatry; 2000 Dec; 57(12):1105-14. PubMed ID: 11115324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of dopamine receptors and transporter genes in neuropsychiatric diseases.
    Fujiwara Y; Yamaguchi K; Tanaka Y; Tomita H; Shiro Y; Kashihara K; Sato K; Kuroda S
    Eur Neurol; 1997; 38 Suppl 1():6-10. PubMed ID: 9276194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area.
    Adelbrecht C; Agid Y; Raisman-Vozari R
    Brain Res Mol Brain Res; 1996 Dec; 43(1-2):291-300. PubMed ID: 9037545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine phenotype and behaviour in animal models: in relation to attention deficit hyperactivity disorder.
    Viggiano D; Ruocco LA; Sadile AG
    Neurosci Biobehav Rev; 2003 Nov; 27(7):623-37. PubMed ID: 14624807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of the brain reward system.
    Abood LG
    NIDA Res Monogr; 1996; 162():34-6. PubMed ID: 9066806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.